Jack Nathan Medical Corp. (TSXV:JNH)

Canada · Delayed Price · Currency is CAD

0.0100

0.00 (0.00%)

Jun 6, 2025, 2:44 PM EST

Jack Nathan Medical Financials Overview

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Revenue	-6.71	8.71	6.89	15.49	9.64	3.85
Revenue Growth	-	26.41%	-55.53%	60.68%	150.21%	6.50%
Gross Profit	-5.42	7.37	5.33	12.44	6.66	3.05
Operating Income	0.54	-2.39	-2.18	-5.2	-6.55	-0.81
Net Income	10.56	7.46	-6.64	-6.9	-7.81	-9.9
Earnings Per Share	0.11	0.08	-0.08	-0.08	-0.10	-0.19
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Canada	-	12.8	11.92	7.12	3.57
Mexico	7.68	6.35	3.57	2.52	0.28
Canada-continuing Operations	1.03	-	-	-	-
Total	8.71	19.14	15.49	9.64	3.85

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Cash & Investments	-0.19	2.2	3.07	1.46	1.06	7.69
Total Debt	0.2	0.24	12.39	4.55	1.16	0.71
Net Cash (Debt)	-0.39	1.96	-9.32	-3.09	-0.09	6.98
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.00	0.02	-0.11	-0.04	-0.00	0.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Operating Cash Flow	-1.87	-6.36	-6.11	-2	-4.34	-0.81
Capital Expenditures	-0.58	-1.18	-4.09	-2.59	-0.95	-0.5
Free Cash Flow	-2.45	-7.54	-10.2	-4.59	-5.29	-1.31
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Gross Margin	-	84.66%	77.39%	80.34%	69.05%	79.19%
Operating Margin	-	-27.45%	-31.71%	-33.57%	-67.95%	-20.91%
Pretax Margin	-7.04%	-28.88%	-31.06%	-45.12%	-85.42%	-267.23%
Profit Margin	-	85.74%	-96.35%	-44.57%	-81.00%	-257.05%
FCF Margin	-	-86.62%	-148.05%	-29.64%	-54.90%	-33.98%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
PE Ratio	0.08	0.35	-	-	-	-
PS Ratio	-0.13	0.30	0.51	0.44	1.73	17.88